ArticleOpen medicine (Warsaw, Poland)2024

Cost-effectiveness of ambroxol in the treatment of Gaucher disease type 2.

Miloš N Milosavljević et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.